METTL3 promotes esophageal squamous cell carcinoma progression and reduces chemosensitivity to paclitaxel through the CASP9/BIRC3-dependent apoptosis pathway.

ABSTRACT:

SUBMITTER: Ji P 

PROVIDER: S-EPMC12624589 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature